Unmixed Adalimumab Biosimilar from United States
Unmixed Adalimumab Biosimilar is a TNF inhibitor monoclonal antibody used for treating rheumatoid arthritis. It is supplied unmixed, without measured doses or retail packaging, and is intended for further formulation. It falls under tariff item 3002.13.00 as an antibody directly involved in the regulation of immunological processes.
Duty Rate — United States → Canada
0%
Import Tips
• Ensure the product is not mixed with other active ingredients or put up for retail sale
• Provide documentation showing the product is obtained by biotechnological processes
• Verify if a permit is required for importing biological drugs under Health Canada regulations